Quinase Xano (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Quinase Xano" in Galician language version.

refsWebsite

Global rank Galician rank

4^th place

6^th place

2^nd place

7^th place

5,225^th place

7,257^th place

7,208^th place

low place

clinicaltrials.gov

Wilks (1989). "Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction". PNAS 86 (5): 1603–7. PMC 286746. PMID 2466296. doi:10.1073/pnas.86.5.1603.
Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM, Schreiber RD (1998). "Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses". Cell 93 (3): 373–83. PMID 9590172. doi:10.1016/S0092-8674(00)81166-6.
Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, Sexl V (2004). "TYK2 is a key regulator of the surveillance of B lymphoid tumors". J. Clin. Invest. 114 (11): 1650–8. PMC 529282. PMID 15578097. doi:10.1172/JCI22315.
Kisseleva; Bhattacharya, S; Braunstein, J; Schindler, CW; et al. (2002-02-20). "Signaling through the JAK/STAT pathway, recent advances and future challenges". Gene 285 (1–2): 1–24. PMID 12039028. doi:10.1016/S0378-1119(02)00398-0.
Craiglow, B. G.; King, B. A. (2015). "Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy". JAMA Dermatology 151: 1110–2. PMID 26107994. doi:10.1001/jamadermatol.2015.1520.

Wilks (1989). "Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction". PNAS 86 (5): 1603–7. PMC 286746. PMID 2466296. doi:10.1073/pnas.86.5.1603.
Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM, Schreiber RD (1998). "Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses". Cell 93 (3): 373–83. PMID 9590172. doi:10.1016/S0092-8674(00)81166-6.
Stoiber D, Kovacic B, Schuster C, Schellack C, Karaghiosoff M, Kreibich R, Weisz E, Artwohl M, Kleine OC, Muller M, Baumgartner-Parzer S, Ghysdael J, Freissmuth M, Sexl V (2004). "TYK2 is a key regulator of the surveillance of B lymphoid tumors". J. Clin. Invest. 114 (11): 1650–8. PMC 529282. PMID 15578097. doi:10.1172/JCI22315.
Kisseleva; Bhattacharya, S; Braunstein, J; Schindler, CW; et al. (2002-02-20). "Signaling through the JAK/STAT pathway, recent advances and future challenges". Gene 285 (1–2): 1–24. PMID 12039028. doi:10.1016/S0378-1119(02)00398-0.
Craiglow, B. G.; King, B. A. (2015). "Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy". JAMA Dermatology 151: 1110–2. PMID 26107994. doi:10.1001/jamadermatol.2015.1520.